Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective.

• Therapeutic Focus: Translating medical, operational and regulatory knowledge into execution while leveraging established KOL and site relationships to drive successful research.
• Integrated Efficiency: The built-in collaboration and efficiencies of working with a single vendor facilitates a streamlined strategy for executing even the most complex global studies. Medpace offers comprehensive and fully-integrated laboratory services including global central laboratories, bioanalytical laboratory, ECG core lab, and imaging core labs, as well as a clinical pharmacology unit.
• Global Reach: With resources around the globe, Medpace skillfully navigates local languages, cultures and processes to avoid delays and missteps—delivering seamless execution amid the complex landscape of global clinical development.
• Organic Growth: Founded in 1992, our purposeful, organic growth provides consistency in leadership, deep institutional experience, and incomparable efficiencies as a top-10 CRO.